Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy
- 21 July 2009
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 54 (4), 334-342
- https://doi.org/10.1016/j.jacc.2008.12.082
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous returnHuman Mutation, 2008
- Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?Current Opinion in Cardiology, 2007
- Genotype–phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethoninMolecular Genetics and Metabolism, 2006
- THE GENETIC BASIS FOR CARDIAC REMODELINGAnnual Review of Genomics and Human Genetics, 2005
- Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathyJournal of the American College of Cardiology, 2004
- Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathyJournal of the American College of Cardiology, 2004
- The Giant Protein TitinCirculation Research, 2004
- Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failureBiochemical and Biophysical Research Communications, 2002
- Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathyNature Genetics, 2002
- Cardiac Ankyrin Repeat Protein Is a Novel Marker of Cardiac HypertrophyHypertension, 2000